JP Patent

JP2004277337A — ピラゾロ［１，５−ａ］ピリミジン誘導体

Assigned to Sumitomo Pharma Co Ltd · Expires 2004-10-07 · 22y expired

What this patent protects

【課題】抗炎症剤、骨吸収抑制剤、抗関節リウマチ剤及び／または抗関節炎剤を提供する。【解決手段】式（１）で表わされる新規なピラゾロ［１，５−ａ］ピリミジン誘導体。【化１】【選択図】なし

USPTO Abstract

【課題】抗炎症剤、骨吸収抑制剤、抗関節リウマチ剤及び／または抗関節炎剤を提供する。【解決手段】式（１）で表わされる新規なピラゾロ［１，５−ａ］ピリミジン誘導体。【化１】【選択図】なし

Drugs covered by this patent

larotrectinib-sulfate (LAROTRECTINIB SULFATE)

Patent Metadata

Patent number: JP2004277337A
Jurisdiction: JP
Classification: —
Expires: 2004-10-07
Drug substance claim: No
Drug product claim: No
Assignee: Sumitomo Pharma Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.